Clinical Trial Update: Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study [Phase 3]

View source ↗

Summary

Phase 3 trial update showing eletriptan provides consistent relief across multiple-dose regimens for migraine with and without aura.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine Without Aura
• Migraine with Aura

Drugs mentioned

• Eletriptan (eletriptan)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Migraine Without Aura, Migraine With Aura | Phase 3 | Status: COMPLETED